Sudden Cardiac Death Screening
On this page
Direct answer
In Italy's Veneto region, mandatory ECG screening of athletes introduced in 1982 was followed by an almost 90 per cent fall in sudden cardiovascular death during sport — the single most quoted statistic in the screening debate, tempered by the counter-evidence that Israel saw no benefit after mandating ECG screening and the United States maintains a history-and-examination strategy without routine ECG. Sudden cardiac death is natural death within an hour of symptom onset (within 24 hours if unwitnessed), with causes stratified sharply by age: coronary disease dominates beyond 35, while in the young the list reads hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, myocarditis, anomalous coronary arteries, channelopathies and commotio cordis. Screening the asymptomatic rests on history, examination and — where policy supports it — a 12-lead ECG; every unexplained death obligates the family to cascade evaluation, because the majority of young victims have heritable disease.
What you must remember
- Definition: natural, unexpected death within one hour of symptom onset (witnessed) or within 24 hours (unwitnessed, last seen well) — sudden arrhythmic death syndrome (SADS) when autopsy is negative.
- Age split: over 35 — coronary artery disease, often with known or latent risk factors; under 35 — HCM, ARVC, channelopathies, myocarditis, anomalous coronaries, aortic disease (Marfan), commotio cordis.
- Veneto data: the Italian experience associated ECG-based pre-participation screening with an approximately 89 per cent reduction in athlete sudden death, largely by detecting HCM and arrhythmogenic disease.
- Counterweights: low event rates, false positives (especially in athletes of African descent with benign T-wave inversion), cost, and the Israeli experience of no observed benefit — know both sides.
- Warning symptoms that outrank any screening programme: exertional syncope or chest pain, palpitations with exercise, unexplained dyspnoea, and a family history of sudden death under 50, unexplained drowning or SIDS.
- Commotio cordis: blunt precordial impact during a narrow vulnerable window on the T-wave upstroke triggering ventricular fibrillation in a structurally normal heart — survival depends on immediate bystander defibrillation.
- Secondary prevention: ICDs for survivors, public access defibrillators and CPR training for communities; screening programmes do not substitute for a chain of survival.
- Family evaluation after a young SCD: collect the autopsy report, screen first-degree relatives with ECG, echo and exercise testing, and pursue molecular autopsy (genetic testing on stored tissue) where available.
Working through the survivor or the bereaved family
Two clinical encounters define this topic. The survivor of an aborted arrest arrives with a structurally normal heart and a negative work-up: the sequence is echocardiography, cardiac MRI for occult cardiomyopathy or myocarditis, exercise testing for catecholaminergic polymorphic VT, sodium-channel blocker challenge for concealed Brugada, and a broad arrhythmia genetics panel; if all remain negative, idiopathic ventricular fibrillation with early repolarisation is the residual label — and an ICD regardless.
The second encounter is the family of a 24-year-old who died during a football match. The duty is systematic: obtain the post-mortem (in India, frequently not performed — document that absence), then screen parents and siblings with ECG and echocardiography, adding exercise testing and prolonged monitoring where suspicion persists. HCM, long QT and ARVC reveal themselves in relatives often enough that the evaluation is standard of care. Where tissue exists, molecular autopsy for channelopathy genes can redirect the entire family's surveillance.
How the exam frames it
The debate question is the staple: "Should ECG screening be mandatory for athletes?" The strong answer runs both sides — Veneto's mortality fall and the ECG's sensitivity for HCM versus false-positive harm, cost and the Israel contradiction — and lands on a defensible position: symptom-and-history screening universally, ECG screening where systems permit, and a low threshold for testing any symptomatic athlete. The second staple is commotio cordis: impact site over the cardiac silhouette, timing in the vulnerable window, structurally normal heart, survival with immediate defibrillation. The Indian angle is sobering: with no national pre-participation programme, patchy AED availability and rare autopsies, most young sudden deaths here are never explained — a fact the candidate can offer as context without pretending it is evidence.
Frequently asked questions
What is the definition of sudden cardiac death?
Natural, unexpected death within one hour of symptom onset when witnessed, or within 24 hours of being last seen well, from a cardiac cause.
Which conditions cause sudden death in athletes under 35?
Hypertrophic and arrhythmogenic cardiomyopathy, congenital coronary anomalies, myocarditis, ion channelopathies and commotio cordis — with coronary disease dominating above age 35.
What did the Italian Veneto screening experience show?
Mandatory ECG-based screening of athletes was associated with an approximately 89 per cent decline in sports-related sudden cardiovascular death over two decades.
What are the main criticisms of population ECG screening?
Low event rates, false-positive results with unnecessary disqualification (notably in athletes of African descent), cost, and the Israeli observation of no benefit after mandatory ECG screening.
What evaluation does a family need after an unexplained young sudden death?
Autopsy review, and cascade screening of first-degree relatives with history, ECG, echocardiography and exercise testing, with molecular autopsy where stored tissue is available.